Yun-Peng Hua - Sun Yat-Sen University

基本信息

浏览量：54

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 126 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Establishment of an Animal Training Model of Duodenoscopy, Choledochoscopy, and Laparoscopy for Cholelithiasis

Baifeng Qian, Junlong Lin,Jianpeng Cai, Zhichao Li,Yunpeng Hua

Journal of visualized experiments JoVE (2025)

引用0浏览0WOS引用

Novel Treatment for Complex Bile Leakage after Liver Transplantation

Zongli Fu, Qian Jian, Zhongqiu Li, Pengrui Cheng, Hanyu Wang, Hanyuan Zhang,Yunpeng Hua,Yi Ma

Journal of visualized experiments JoVE (2025)

引用0浏览0WOS引用

Neoadjuvant Immune-Checkpoint Blockade Therapy Combined with TACE for Resectable Hepatocellular Carcinoma with High Recurrence Risk: A Phase II, Single-Arm Clinical Trial (MORNING)

Li Tan,Lixia Xu, Shun-Li Shen, Dongming Li,Yunpeng Hua, Shaoqiang Li,Lijian Liang,Qiang He, Qi Zhou, Wenxuan Xie, Zebin Chen,Jian Wu,Jiaping Li, Wenzhe Fan, Wenquan Zhuang,Lili Chen,Shiting Feng, Sui Peng,Jiping Wang,Ming Kuang

Journal of Clinical Oncology（2024）

引用0浏览0引用

Supplementary Figure S1 from Toripalimab Plus Bevacizumab As First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial

Yajin Chen,Chengyou Du,Shunli Shen, Wu Zhang,Yunfeng Shan, Ang Lyu,Jianhui Wu,Changzhen Shang, Xuan Luo,Jinxing Wei,Heng Xiao,Jianguo Qiu,Yunpeng Hua,Shutong Wang, Ting Wang,Shengjie Dai, Shuhao Zhang, Bingying Xie, Yinghao Wu,Chunyi Hao

crossref（2024）

引用0浏览0引用

Supplementary Table S2 from Toripalimab Plus Bevacizumab As First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial

crossref（2024）

引用0浏览0引用

Adjuvant Transarterial Chemoembolization with Sorafenib for Portal Vein Tumor Thrombus

Zhenwei Peng,Wenzhe Fan,Zelong Liu,Han Xiao,Jian Wu,Rong Tang,Jianfei Tu,Liangliang Qiao,Fuxi Huang,Wenxuan Xie,Wenquan Zhuang,Wenbo Guo,Shaoqiang Li,Yunpeng Hua,Shunli Shen,Qiang He,Dongming Li,Jiaping Li,Ming Kuang

JAMA SURGERYno. 6 (2024): 616-624

引用1浏览0WOS引用

Supplementary Figure S3 from Toripalimab Plus Bevacizumab As First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial

Yajin Chen,Cheng-You Du,Shunli Shen,Wu Zhang,Yunfeng Shan, Ang Lyu,Jianhui Wu,Changzhen Shang, Xuan Luo,Jinxing Wei,Heng Xiao,Jianguo Qiu,Yunpeng Hua,Shutong Wang, Ting Wang,Shengjie Dai, Shuhao Zhang, Bingying Xie, Yinghao Wu,Chunyi Hao

Clinical Cancer Research (2024)

引用1浏览0引用

Appraising the Causal Effects of Circulating Micronutrients on Liver Cirrhosis: Evidence from Large‐scale Mendelian Randomization Analysis

Junlong Lin,Jialin Chen, Zhichao Li,Baifeng Qian,Yunpeng Hua

PORTAL HYPERTENSION & CIRRHOSISno. 3 (2024): 160-170

引用0浏览0引用

胰胆管疾病内镜诊疗的新进展、新理念

沈建明, 郭宇,华赟鹏

Electronic Journal of Medical Operationsno. 3 (2023)

引用0浏览0引用

Somatic Mutation Profiles Revealed by Next Generation Sequencing (NGS) in 39 Chinese Hepatocellular Carcinoma Patients

Lixin Ke,Jianming Shen, Jikun Feng,Jialin Chen,Shunli Shen,Shaoqiang Li,Ming Kuang,Lijian Liang,Cuncun Lu,Dongming Li,Qiang He,Baogang Peng,Yunpeng Hua

Frontiers in Molecular Biosciences（2022）

引用8浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn